<DOC>
	<DOC>NCT00863343</DOC>
	<brief_summary>The primary objective of this study is to evaluate the performance of the MSDÂ® Influenza Test in detecting influenza A and influenza B in subjects presenting with influenza-like-illness (ILI).</brief_summary>
	<brief_title>Clinical Validation of the Point-of-Care MSD Influenza Test</brief_title>
	<detailed_description>This is a multicenter, prospective study to evaluate the performance of the MSD Influenza Test for the detection and differentiation of influenza A (including A/H1, A/H3, and A/H5 subtypes) and influenza B. Nasal swabs from subjects presenting at the clinical care facility with ILI will be collected and tested on the MSD Influenza Test. Results from the Test will be compared to results obtained from viral culture performed on a second nasal swab at a reference laboratory.</detailed_description>
	<mesh_term>Influenza, Human</mesh_term>
	<criteria>Any subject (all ages) presenting with ILI (defined as fever [subjective or documented] and cough or sore throat), and suspected of having influenza. Subject (parent, guardian, or authorized legal representative) gives informed consent or assent (child) to the study, and provides signed authorization for use and disclosure of protected health information. Any subject classified as "high risk" for exposure to avian or novel influenza, as determined by a RiskAssessment Questionnaire. Subjects who had prior nasal wash/aspirate or nasopharyngeal wash/aspirate specimens collected for routine healthcare purposes within the same suspected influenza infection episode.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Influenza infections</keyword>
	<keyword>Orthomyxoviridae infections</keyword>
</DOC>